Business Description
Aptevo Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US03835L1089
Description
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.13 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | -0.19 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33 | |||||
| 3-Year EPS without NRI Growth Rate | 35.2 | |||||
| 3-Year FCF Growth Rate | 52 | |||||
| 3-Year Book Growth Rate | -44.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.67 | |||||
| 9-Day RSI | 41.24 | |||||
| 14-Day RSI | 42.8 | |||||
| 6-1 Month Momentum % | -58.92 | |||||
| 12-1 Month Momentum % | -92.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.64 | |||||
| Quick Ratio | 2.64 | |||||
| Cash Ratio | 2.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -64 | |||||
| Shareholder Yield % | -123.24 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -103.12 | |||||
| ROA % | -58.01 | |||||
| ROIC % | -312.25 | |||||
| ROC (Joel Greenblatt) % | -461.92 | |||||
| ROCE % | -126.01 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.02 | |||||
| Price-to-Tangible-Book | 0.02 | |||||
| EV-to-EBIT | 0.31 | |||||
| EV-to-EBITDA | 0.32 | |||||
| EV-to-Forward-Revenue | 0.07 | |||||
| EV-to-FCF | 0.77 | |||||
| Price-to-Net-Current-Asset-Value | 0.05 | |||||
| Price-to-Net-Cash | 0.07 | |||||
| Earnings Yield (Greenblatt) % | 322.58 | |||||
| FCF Yield % | -479.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptevo Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -66.774 | ||
| Beta | 0.64 | ||
| Volatility % | 57.78 | ||
| 14-Day RSI | 42.8 | ||
| 14-Day ATR (€) | 0.049966 | ||
| 20-Day SMA (€) | 4.953 | ||
| 12-1 Month Momentum % | -92.36 | ||
| 52-Week Range (€) | 0.0191 - 77.176 | ||
| Shares Outstanding (Mil) | 3.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptevo Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptevo Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptevo Therapeutics Inc Frequently Asked Questions
What is Aptevo Therapeutics Inc(FRA:AP8)'s stock price today?
The current price of FRA:AP8 is €4.95. The 52 week high of FRA:AP8 is €77.18 and 52 week low is €0.02.
When is next earnings date of Aptevo Therapeutics Inc(FRA:AP8)?
The next earnings date of Aptevo Therapeutics Inc(FRA:AP8) is 2024-05-10 Est..
Does Aptevo Therapeutics Inc(FRA:AP8) pay dividends? If so, how much?
Aptevo Therapeutics Inc(FRA:AP8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers